enGene Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $11.0M |
| FY2022 | $47.4M | $23.9M | $20.4M |
| FY2023 | $14.5M | $87.0M | $81.5M |
| FY2024 | $38.6M | $311.2M | $173.0M |
| FY2025 | $53.8M | $221.5M | $50.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $11.0M |
| FY2022 | $47.4M | $23.9M | $20.4M |
| FY2023 | $14.5M | $87.0M | $81.5M |
| FY2024 | $38.6M | $311.2M | $173.0M |
| FY2025 | $53.8M | $221.5M | $50.2M |